Southern Acids (M) Berhad (KLSE:SAB)
Malaysia · Delayed Price · Currency is MYR 3.090
-0.010 (-0.32%)
At close: Aug 28, 2026
Southern Acids (M) Berhad Income Statement
Financials in millions MYR. Fiscal year is April - March.
Millions MYR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 928.49 | 918.87 | 1,091 | 907.96 | 1,100 | 1,176 |
Other Revenue | 14.69 | 14.69 | 15.48 | 12.26 | 6.86 | 4.63 |
| 943.18 | 933.56 | 1,106 | 920.22 | 1,107 | 1,181 | |
Revenue Growth | -13.55% | -15.59% | 20.19% | -16.85% | -6.28% | 58.31% |
Cost of Revenue | 713.06 | 722.8 | 865.51 | 732.03 | 861.8 | 883.41 |
Gross Profit | 230.12 | 210.76 | 240.5 | 188.2 | 244.94 | 297.47 |
Selling, General & Admin | 88.85 | 88.23 | 87.98 | 81.55 | 81.32 | 76.8 |
Other Operating Expenses | 18.49 | 18.12 | 52.78 | 37.27 | 63.65 | 46.55 |
Operating Expenses | 135.03 | 134.04 | 166.81 | 143.67 | 169.24 | 146.86 |
Operating Income | 95.09 | 76.72 | 73.69 | 44.52 | 75.7 | 150.61 |
Interest Expense | -1.36 | -1.2 | -1.95 | -0.81 | -0.93 | -0.8 |
Earnings From Equity Investments | - | - | 0.52 | -0.55 | 0.14 | 0.04 |
Pretax Income | 93.73 | 75.52 | 72.26 | 43.17 | 74.91 | 149.86 |
Income Tax Expense | 25.57 | 23.29 | 21.3 | 18.63 | 20.94 | 31.74 |
Earnings From Continuing Operations | 68.16 | 52.23 | 50.96 | 24.54 | 53.97 | 118.12 |
Minority Interest in Earnings | -15.94 | -14.85 | -14.26 | -10.91 | -20.68 | -23.7 |
Net Income | 52.23 | 37.38 | 36.7 | 13.63 | 33.29 | 94.42 |
Net Income to Common | 52.23 | 37.38 | 36.7 | 13.63 | 33.29 | 94.42 |
Net Income Growth | 50.49% | 1.84% | 169.19% | -59.05% | -64.74% | 152.75% |
Shares Outstanding (Basic) | 136 | 137 | 137 | 137 | 137 | 137 |
Shares Outstanding (Diluted) | 136 | 137 | 137 | 137 | 137 | 137 |
Shares Change | -0.96% | - | - | - | - | - |
EPS (Basic) | 0.38 | 0.27 | 0.27 | 0.10 | 0.24 | 0.69 |
EPS (Diluted) | 0.38 | 0.27 | 0.27 | 0.10 | 0.24 | 0.69 |
EPS Growth | 51.95% | 1.84% | 169.19% | -59.05% | -64.74% | 152.75% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 74.57 | 80.8 | 12.67 | -5.9 | 84.81 | 64.75 |
Free Cash Flow Per Share | 0.55 | 0.59 | 0.09 | -0.04 | 0.62 | 0.47 |
Dividend Per Share | 0.050 | 0.050 | 0.050 | 0.050 | 0.050 | 0.050 |
Dividend Growth | 0% | 0% | 0% | 0% | 0% | 0% |
Gross Margin | 24.40% | 22.58% | 21.75% | 20.45% | 22.13% | 25.19% |
Operating Margin | 10.08% | 8.22% | 6.66% | 4.84% | 6.84% | 12.75% |
Profit Margin | 5.54% | 4.00% | 3.32% | 1.48% | 3.01% | 8.00% |
Free Cash Flow Margin | 7.91% | 8.65% | 1.15% | -0.64% | 7.66% | 5.48% |
EBITDA | 122.23 | 103.3 | 98.45 | 68.03 | 98.57 | 172.7 |
EBITDA Margin | 12.96% | 11.06% | 8.90% | 7.39% | 8.91% | 14.63% |
D&A For EBITDA | 27.14 | 26.58 | 24.76 | 23.5 | 22.87 | 22.09 |
EBIT | 95.09 | 76.72 | 73.69 | 44.52 | 75.7 | 150.61 |
EBIT Margin | 10.08% | 8.22% | 6.66% | 4.84% | 6.84% | 12.75% |
Effective Tax Rate | 27.28% | 30.84% | 29.48% | 43.15% | 27.95% | 21.18% |